World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
48719
World Ranking
8443
National Ranking
96

Overview

Leo Niskanen is affiliated with the University of Helsinki in Finland. Their research primarily focuses on the field of Medicine, with a significant concentration in Endocrinology, Diabetes and Metabolism. In addition, their work encompasses Surgery, Nephrology, Epidemiology, and Molecular Biology as notable subfields.

The scientist's main topics of study include:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Metabolism, Diabetes, and Cancer
  • Dialysis and Renal Disease Management
  • Diabetes and associated disorders
  • Chronic Kidney Disease and Diabetes

Leo Niskanen has contributed to publications in a variety of journals, with frequent venues including:

  • Primary care diabetes
  • International Urology and Nephrology
  • The Lancet Diabetes & Endocrinology
  • JAMA Network Open
  • Diabetes & Metabolism

Recent papers authored or coauthored by Niskanen include:

  • Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial (2021, The Lancet Diabetes & Endocrinology)
  • Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery (2022, JAMA Network Open)
  • Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study (2023, Diabetes & Metabolism)
  • Oral health associated with incident diabetes but not other chronic diseases: A register-based cohort study (2022, Frontiers in Oral Health)
  • The majority of type 2 diabetic patients in Finnish primary care are at very high risk of cardiovascular events: A cross-sectional chart review study (STONE HF) (2021, Primary care diabetes)

Their frequent coauthors include:

  • Tomi-Pekka Tuomainen
  • Mounir Ould Setti
  • Jari Haukka
  • Thomas Nyström
  • Avraham Karasik

Best Publications

  • THE METABOLIC SYNDROME AND TOTAL AND CARDIOVASCULAR DISEASE MORTALITY IN MIDDLE-AGED MEN

    Hanna-Maaria Lakka;David E. Laaksonen;Timo A. Lakka;Leo K. Niskanen

  • Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

    Lennart Hansson;Lars H Lindholm;Leo Niskanen;Jan Lanke

  • 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

    Jari Tiihonen;Jari Tiihonen;Jouko Lönnqvist;Kristian Wahlbeck;Timo Klaukka

  • Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

    Arne Astrup;Stephan Rössner;Luc Van Gaal;Aila Rissanen

  • Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

    David E. Laaksonen;Hanna-Maaria Lakka;Leo K. Niskanen;George A. Kaplan

  • Testosterone and Sex Hormone–Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men

    David E. Laaksonen;Leo Niskanen;Kari Punnonen;Kristiina Nyyssönen

  • Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-Aged Men: A Prospective Cohort Study

    Leo K. Niskanen;David E. Laaksonen;Kristiina Nyyssönen;Georg Alfthan

  • Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

    Juhani Partanen;Leo Niskanen;Juha Lehtinen;Esa Mervaala

  • Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome.

    David E. Laaksonen;Hanna-Maaria Lakka;Jukka T. Salonen;Leo K. Niskanen

  • Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

    William T Cefalu;William T Cefalu;Lawrence A Leiter;Kun-Ho Yoon;Pablo Arias

  • Physical Activity in the Prevention of Type 2 Diabetes The Finnish Diabetes Prevention Study

    David E. Laaksonen;Jaana Lindström;Timo A. Lakka;Johan G. Eriksson

  • Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.

    A Astrup;R Carraro;N Finer;A Harper

  • Medial Artery Calcification A Neglected Harbinger of Cardiovascular Complications in Non–Insulin-Dependent Diabetes Mellitus

    Seppo Lehto;Leo Niskanen;Matti Suhonen;Tapani Rönnemaa

  • Sex hormones, inflammation and the metabolic syndrome: a population-based study.

    David E. Laaksonen;Leo Niskanen;Kari Punnonen;Kristiina Nyyssönen

  • Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome.

    Timo A. Lakka;David E. Laaksonen;Hanna Maaria Lakka;Niko Männikkö

  • Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

    M. I. J. Uusitupa;L. K. Niskanen;O. Siitonen;E. Voutilainen

  • Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus

    Seppo Lehto;Leo Niskanen;Tapani Rönnemaa;Markku Laakso

  • Comparison of Insulin Regimens in Patients with Non-Insulin-Dependent Diabetes Mellitus

    H Yki-Järvinen;M Kauppila;E Kujansuu;J Lahti

  • Inflammation, Abdominal Obesity, and Smoking as Predictors of Hypertension

    Leo Niskanen;David E. Laaksonen;Kristiina Nyyssönen;Kari Punnonen

  • Age and gender dependency of baroreflex sensitivity in healthy subjects

    Tomi Laitinen;Juha Hartikainen;Esko Vanninen;Leo Niskanen

Frequent Co-Authors

Heimo Viinamäki
Heimo Viinamäki University of Eastern Finland
Matti Uusitupa
Matti Uusitupa University of Eastern Finland
Markku Laakso
Markku Laakso University of Eastern Finland
Jari Haukka
Jari Haukka University of Helsinki
Sirkka Keinänen-Kiukaanniemi
Sirkka Keinänen-Kiukaanniemi Oulu University Hospital
Kirsi Honkalampi
Kirsi Honkalampi University of Eastern Finland
Karl-Heinz Herzig
Karl-Heinz Herzig Oulu University Hospital
Markku Peltonen
Markku Peltonen Finnish Institute for Health and Welfare (THL)
Rainer Rauramaa
Rainer Rauramaa University of Eastern Finland
Jukka T. Salonen
Jukka T. Salonen University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA offers diverse paths beyond traditional MD programs. Online degrees in nursing and healthcare are increasingly popular, providing flexibility for working professionals and those seeking career advancement.

Many registered nurses are now opting for best online rn to bsn programs without clinical requirements, saving time and allowing students to balance studies with work. For those aspiring to advance further, options such as accelerated msn to dnp programs open doors to leadership and specialized roles within healthcare.

Cost remains a significant factor for many students. Fortunately, affordable dnp programs make doctoral-level nursing education more accessible, helping reduce student debt while providing advanced skills. For those entering the field, lpn programs offer a fast-track entry into healthcare, equipping graduates for key support roles in patient care.

These online pathways offer flexibility, affordability, and new opportunities for those interested in medical careers or looking to upskill within the field.

Best Scientists Citing Leo Niskanen

Trending Scientists

Recently Published Articles